Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Novartis Will Co-Develop UCB’s Alpha-Syn Inhibitor For Parkinson’s
02 Dec 2021
•
By
Joseph Haas
Novartis and UCB will collaborate on a disease-modifying Parkinson's therapy
More from Deals
More from Business